Notalgia Paresthetica (NP) Case Study

Click here for a PDF version of this case study

Study Characteristics

Study Phase: II
Patient Population: 126 patients with Notalgia Paresthetica (NP) (Pruritus associated with NP)
IP Route of Administration: Systemic (oral)
Site Distribution: 33 sites (USA and Canada)
Study Procedures: Photographs, Pharmacokinetics, Electrocardiograms

Study Challenges

Patient awareness: Challenge in advertisement as patients are often unaware of the name of their condition

Run-in period (screening): To ensure the enrollment of highly compliant patients and those with consistent itch

Patient compliance: Primary endpoints were relying on patient-reported assessments

Uncommon indication: PI with little experience in this indication

Study Highlights

Increased support for low-performing sites

Engaged with low-enrolling sites to ensure proper use of their local campaign budget

Creative advertising

Digital and local innovative marketing tactics to encourage patients to participate

Notalgia paresthetica cro specialty

Innovaderm managed 100% of the notalgia paresthetica studies (as per clinical trials.gov)

High compliance rate

Additional patient compensation for fully completed diary

Get notified to have the latest trends and be at the forefront of dermatology clinical research and innovation.

Subscribe to our newsletter

Case Study

Hidradenitis Suppurativa (HS) Case study

Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this HS study and this resulted in: Enrollment completed 3 months ahead of schedule Study Characteristics Study Phase: II Patient Population: Hidradenitis Suppurativa IP Route of Administration: Systemic - Subcutaneous Site distribution: 25 in North America and 16 in Europe […]

Webinar

Clinical Trials Information System (CTIS) Webinar

📣Attention all clinical trial sponsors who are planning to conduct a study in the EU or EEA! Beginning on January 31, 2023, the Clinical Trials Information System (CTIS) must be used to submit any new clinical trial application in these regions. This new process permits a single application to secure authorizations in up to 30 […]

Case Study

Palmoplantar Pustulosis (PPP) Case Study

Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this PPP study and this resulted in: Enrollment completed 3 weeks ahead of schedule; Successful study and satisfied sponsor Study Characteristics Study Phase: II Patient Population: Palmoplantar pustulosis IP Route of Administration: Systemic Sites Distribution: 17 sites in 2 countries […]